R Rheingans

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?
    Richard D Rheingans
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    Pediatr Infect Dis J 25:S48-55. 2006
  2. ncbi Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries
    Richard D Rheingans
    Hubert Department of Global Health, Rollins School of Public Health, Emory University, Georgia 30322, USA
    J Infect Dis 200:S16-27. 2009
  3. ncbi Beyond the Millennium Development Goals: public health challenges in water and sanitation
    R Rheingans
    Center for Global Safe Water, Hubert Department of Global Health, Rollins School of Public Health at Emory University, Atlanta, GA 30322, USA
    Glob Public Health 1:31-48. 2006
  4. ncbi Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries
    Richard D Rheingans
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, USA
    Rev Panam Salud Publica 21:205-16. 2007
  5. ncbi Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries
    Richard D Rheingans
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, USA
    Rev Panam Salud Publica 21:192-204. 2007
  6. ncbi Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya
    Jacqueline E Tate
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 200:S76-84. 2009
  7. ncbi [Potential cost effectiveness of a rotavirus vaccine in Chile]
    Dagna Constenla
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    Rev Med Chil 134:679-88. 2006
  8. ncbi Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine
    E T Isakbaeva
    Viral Gastroenteritis Section, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 25:373-80. 2007
  9. ncbi Economic impact of a rotavirus vaccine in Brazil
    Dagna O Constenla
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    J Health Popul Nutr 26:388-96. 2008
  10. ncbi Global challenges in water, sanitation and health
    Christine L Moe
    Center for Global Safe Water, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    J Water Health 4:41-57. 2006

Collaborators

Detail Information

Publications12

  1. ncbi Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?
    Richard D Rheingans
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    Pediatr Infect Dis J 25:S48-55. 2006
    ..Although methodologic limitations exist in applying the QALY approach to childhood vaccines, their use in cost effectiveness analyses allows decision makers to consider the full health benefits of rotavirus and other vaccines...
  2. ncbi Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries
    Richard D Rheingans
    Hubert Department of Global Health, Rollins School of Public Health, Emory University, Georgia 30322, USA
    J Infect Dis 200:S16-27. 2009
    ..Rotavirus is the leading cause of severe gastroenteritis in children worldwide. We evaluated the economic burden of rotavirus and the cost-effectiveness of vaccination from the health care perspective...
  3. ncbi Beyond the Millennium Development Goals: public health challenges in water and sanitation
    R Rheingans
    Center for Global Safe Water, Hubert Department of Global Health, Rollins School of Public Health at Emory University, Atlanta, GA 30322, USA
    Glob Public Health 1:31-48. 2006
    ....
  4. ncbi Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries
    Richard D Rheingans
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, USA
    Rev Panam Salud Publica 21:205-16. 2007
    ..To estimate the costs, benefits and cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries: Argentina, Brazil, Chile, the Dominican Republic, Honduras, Mexico, Panama, and Venezuela...
  5. ncbi Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries
    Richard D Rheingans
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, USA
    Rev Panam Salud Publica 21:192-204. 2007
    ....
  6. ncbi Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya
    Jacqueline E Tate
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 200:S76-84. 2009
    ..The projected impact and cost-effectiveness of rotavirus vaccination are important for supporting rotavirus vaccine introduction in Africa, where limited health intervention funds are available...
  7. ncbi [Potential cost effectiveness of a rotavirus vaccine in Chile]
    Dagna Constenla
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    Rev Med Chil 134:679-88. 2006
    ..Cost effectiveness studies are essential to assess the real value of interventions with preventive or therapeutic objectives...
  8. ncbi Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine
    E T Isakbaeva
    Viral Gastroenteritis Section, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 25:373-80. 2007
    ..Vaccination would be cost-effective with vaccine prices in a range of US$ 2-25 per child. However, the cost-effectiveness is greatly influenced by mortality, vaccine price and vaccine efficacy...
  9. ncbi Economic impact of a rotavirus vaccine in Brazil
    Dagna O Constenla
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    J Health Popul Nutr 26:388-96. 2008
    ..At a vaccine price of US$ 7-8 per dose, the cost-effectiveness ratio would be US$ 643 per DALY averted. Rotavirus vaccination can reduce the burden of gastroenteritis due to rotavirus at a reasonable cost-effectiveness ratio...
  10. ncbi Global challenges in water, sanitation and health
    Christine L Moe
    Center for Global Safe Water, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    J Water Health 4:41-57. 2006
    ....
  11. ncbi Economic impact of a rotavirus vaccination program in Mexico
    Dagna Constenla
    Department of Global Health, Emory University, Atlanta, Georgia, United States of America
    Rev Panam Salud Publica 25:481-90. 2009
    ..To evaluate the cost and benefits of a national rotavirus childhood vaccination program in Mexico...
  12. ncbi [Assessment of the economic impact of the antiretroviral vaccine in Venezuela]
    Dagna Constenla
    Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
    Rev Panam Salud Publica 20:213-22. 2006
    ....